FILTER

Refine your search with the following facets to narrow down your results.

6 Current news of Cancer Therapeutics CRC

Cancer Therapeutics reveals proof of concept for second development drug

06-Jul-2012 - Cancer Therapeutics announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) ...

breast cancer cancer therapeutics high-throughput screening +1

Cancer Therapeutics’ first product achieves preclinical proof of concept

04-Apr-2012 - Cancer Therapeutics announced positive preclinical results for CTX-0294945 as an adjuvant therapy to the cancer drug Avastin (bevacizumab - Genentech/Roche). The data is presented at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago, USA.CTX-0294945 is a ...

cancer

Cancer Therapeutics CRC Enters Collaboration with Duke University to develop drugs for the treatment of cancer

06-Oct-2009 - Cancer Therapeutics CRC Pty Ltd announced a collaboration with Duke University to discover and develop new drugs for the treatment of many forms of cancer, based on research undertaken by the laboratory of Duke Professor Patrick Casey. Professor Casey and his team at Duke have been ...

drug development enzymes inhibitors

Novation and Cancer Therapeutics establish collaboration for the discovery and development of new cancer therapies

17-Jun-2009 - Novation Pharmaceuticals Inc, Vancouver, Canada and Cancer Therapeutics CRC Pty Ltd Melbourne, Australia, (CTx) announced a joint collaboration to identify potent small-molecule compounds for two very important but highly intractable oncology targets, c-myc and hSSB1. The collaboration will ...

chemotherapy DNA damage Expression +5

Cytopia cancer program reaches important milestone at Cancer Therapeutics CRC

27-May-2009 - Cytopia Limited announced significant progress by Cancer Therapeutics CRC Pty Ltd (CTx) towards the identification of a pre-clinical drug candidate. This candidate is based on intellectual property licensed from Cytopia to CTx. In May 2008, Cytopia and CTx entered into an agreement where CTx ...

adhesion inhibitors

Cytopia announces novel anti-cancer drug development collaboration

13-May-2008 - Cytopia Limited announced that it has entered into an anti-cancer drug discovery and development collaboration with Cancer Therapeutics CRC Pty Ltd. This agreement leverages Cytopia's early stage drug discovery pipeline of kinase inhibitors, a class of targeted therapeutics that is one of the ...

brain tumors Enzyme inhibitors +2